Water

Identification

Name
Water
Accession Number
DB09145
Type
Small Molecule
Groups
Approved
Description

Water (chemical formula: H2O) is a transparent fluid which forms the world's streams, lakes, oceans and rain, and is the major constituent of the fluids of organisms. As a chemical compound, a water molecule contains one oxygen and two hydrogen atoms that are connected by covalent bonds. Water is a liquid at standard ambient temperature and pressure, but it often co-exists on Earth with its solid state, ice; and gaseous state, steam (water vapor).

Structure
Thumb
Synonyms
  • agua
  • Dihydrogen oxide
  • Purified water
  • Sterile water
  • Water purified
External IDs
B1217 / NSC-147337 / R-718
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Airlife Sterile Water for Inhalation USPLiquid100 %Respiratory (inhalation)Cardinal Health Medical Products And Services1990-12-312011-08-29Canada
Bacteriostatic WaterSolution1 mL/1mLIntramuscular; Intravenous; SubcutaneousMedical Purchasing Solutions, Llc2005-04-30Not applicableUs
Bacteriostatic WaterSolution1 mL/1mLIntramuscular; Intravenous; SubcutaneousRemedy Repack2017-05-122018-03-07Us
Bacteriostatic WaterInjection, solution1 mL/1mLIntramuscular; Intravenous; SubcutaneousMesource Pharmaceuticals2014-07-07Not applicableUs
Bacteriostatic WaterInjection, solution1 mL/1mLIntramuscular; Intravenous; SubcutaneousHospira, Inc.2005-04-30Not applicableUs
Bacteriostatic WaterInjection, solution1 mL/1mLIntramuscular; Intravenous; SubcutaneousGeneral Injectables & Vaccines2010-08-01Not applicableUs
Bacteriostatic WaterInjection, solution1 mL/1mLIntramuscular; Intravenous; SubcutaneousPhysicians Total Care, Inc.1982-10-272012-06-30Us
Bacteriostatic WaterInjection, solution1 mL/1mLIntramuscularRemedy Repack2013-07-102014-07-10Us
Bacteriostatic WaterInjection, solution1 mL/1mLIntramuscularRemedy Repack2013-10-312016-11-08Us
Bacteriostatic Water for Injection USPLiquid100 %Intramuscular; Intravenous; SubcutaneousOmega Laboratories Ltd1994-12-31Not applicableCanada
Generic Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Sterile DiluentInjection1 mL/1mLIntravenousTeva Parenteral Medicines, Inc.2008-04-23Not applicableUs
Sterile DiluentInjection1 mL/1mLIntravenousTeva Parenteral Medicines, Inc.2008-04-232012-02-28Us
Sterile WaterInjection, solution1000 mL/1000mLIntravenousFresenius Kabi2017-11-24Not applicableUs
Sterile WaterInjection, solution1 mL/1mLIntramuscular; Intravenous; SubcutaneousWest-Ward Pharmaceuticals Corp.2015-09-03Not applicableUs
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
37.4Liquid99.9974 g/100mLOralJesus Glory Bio Co.,ltd.2017-08-09Not applicableUs
37.4Liquid99.9974 g/100LOralJesus Glory Bio Co.,ltd.2017-08-09Not applicableUs
A-Med brand First Aid Eye and Skin-RinseSolution98.577 mL/100mLOphthalmicOliver Landon Intl Inc.2013-11-01Not applicableUs
Aerowash Eyewash and Skin-RinseSolution98.577 mL/100mLOphthalmicAero Healthcare2015-05-01Not applicableUs
Boraqua Eye WashSolution99.05 mL/100mLOphthalmicGenuine Drugs2015-04-20Not applicableUs
Bouton Eye WashRinse98.6 mL/100mLOphthalmicAaxis Pacific2010-01-152010-05-07Us
Bouton Eye WashRinse98.6 mL/100mLOphthalmicAaxis Pacific2010-01-15Not applicableUs
Buffered Eye-LertLiquid98 mL/100mLOphthalmicNorth Safety Products2010-06-06Not applicableUs
CEDERROTH Emergency Eye WashLiquid99 mL/100mLOphthalmicCederroth Ab2014-03-132014-12-31Us
CEDERROTH Emergency Eye WashLiquid0.99 mL/1mLOphthalmicOrkla Care Ab2013-08-232014-12-31Us
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
10 Person ANSIWater (98.6 mL/100mL) + Acetaminophen (325 mg/1) + Acetylsalicylic acid (325 mg/1) + Bacitracin zinc (400 [iU]/1g) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (0.40 mL/100mL) + Benzocaine (6 mL/100mL) + Ethanol (60 mL/100mL) + Ibuprofen (200 mg/1) + Lidocaine (0.5 1/100g) + Neomycin sulfate (5 mg/1g) + Polymyxin B Sulfate (5000 [iU]/1g)KitGenuine First Aid2010-04-24Not applicableUs
25 Person ANSIWater (98.6 mL/100mL) + Acetaminophen (325 mg/1) + Acetylsalicylic acid (325 mg/1) + Bacitracin zinc (400 [iU]/1g) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (0.40 mL/100mL) + Benzocaine (6 mL/100mL) + Ethanol (60 mL/100mL) + Ethanol (62 g/100g) + Ibuprofen (200 mg/1) + Isopropyl Alcohol (70 mL/100mL) + Lidocaine (0.5 g/100g) + Neomycin sulfate (5 mg/1g) + Polymyxin B Sulfate (5000 [iU]/1g)KitGenuine First Aid2010-04-25Not applicableUs
50 Person ANSIWater (98.16 mL/100mL) + Acetaminophen (325 mg/1) + Acetylsalicylic acid (325 mg/1) + Bacitracin zinc (400 [iU]/1g) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (0.40 mL/100mL) + Benzocaine (6 mL/100mL) + Ethanol (60 mL/100mL) + Ethanol (62 g/100g) + Ibuprofen (200 mg/1) + Isopropyl Alcohol (70 mL/100mL) + Lidocaine (0.5 g/100g) + Neomycin sulfate (5 mg/1g) + Polymyxin B Sulfate (5000 [iU]/1g)KitGenuine First Aid2010-06-02Not applicableUs
A.P.L. - Pws-liqWater (10 ml) + Chorionic Gonadotropin (Human) (10000 unit)Liquid; Powder, for solutionIntramuscularWyeth Ayerst Canada Inc.1998-11-112001-06-01Canada
ACME FIRST AID Contains 404 PIECESWater (98.16 mL/100mL) + Acetylsalicylic acid (81 mg/1) + Bacitracin zinc (400 [iU]/1g) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (0.40 mL/100mL) + Benzocaine (6 mL/100mL) + Ethanol (60 mL/100mL) + Isopropyl Alcohol (70 mL/100mL) + Lidocaine (0.5 g/100g) + Neomycin sulfate (5 mg/1g) + Polymyxin B Sulfate (5000 [iU]/1g)KitAcme United Corporation2010-04-27Not applicableUs
Activase RT-PAWater (50 ml) + Alteplase (50 mg)Liquid; Powder, for solutionIntravenousHoffmann La Roche1998-04-12Not applicableCanada
Activase RT-PAWater (100 ml) + Alteplase (100 mg)Liquid; Powder, for solutionIntravenousHoffmann La Roche1996-12-31Not applicableCanada
Antithrombin III ImmunoWater (30 ml) + Antithrombin III human (1650 unit)Powder, for solutionIntravenousBaxter Ag1999-07-052011-10-07Canada
Antithrombin III NfWater (20 ml) + Antithrombin III human (1100 unit)Kit; Powder, for solutionIntravenousBaxalta Canada Corporation1999-07-05Not applicableCanada
Antithrombin III NfWater (10 ml) + Antithrombin III human (550 unit)Kit; Powder, for solutionIntravenousBaxalta Canada Corporation1999-07-05Not applicableCanada
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Bacteriostatic WaterWater (1 mg/1mL)Injection, solutionIntramuscular; Intravenous; SubcutaneousFresenius Kabi2000-10-08Not applicableUs
Sterile WaterWater (1 mL/1mL)SolutionIntravenousB. Braun Medical Inc.2010-06-242013-09-01Us
Sterile WaterWater (1 mL/1mL)Injection, solutionIntravenousA S Medication Solutions1990-09-30Not applicableUs
Sterile WaterWater (1 mL/1mL)Injection, solutionIntravenousAMERICAN REGENT, INC.1980-01-012014-09-03Us
Sterile WaterWater (1 mL/1mL)Injection, solutionIntravenousRemedy Repack2015-06-192016-06-19Us
Sterile WaterWater (1 mL/1mL)SolutionIntravenousB. Braun Medical Inc.2011-09-072013-09-01Us
Sterile WaterWater (1 mL/1mL)Injection, solutionIntravenousAMERICAN REGENT, INC.1990-09-302012-12-14Us
Sterile WaterWater (5 mL/5mL)SolutionIntravenousGeneral Injectables & Vaccines2010-09-012017-01-16Us
Sterile WaterWater (1 mL/1mL)LiquidIntravenousHospira, Inc.1971-06-232018-08-27Us
Sterile WaterWater (1 mL/1mL)SolutionIntravenousB. Braun Medical Inc.2010-06-242013-09-01Us
Categories
UNII
059QF0KO0R
CAS number
7732-18-5
Weight
Average: 18.0153
Monoisotopic: 18.010564686
Chemical Formula
H2O
InChI Key
XLYOFNOQVPJJNP-UHFFFAOYSA-N
InChI
InChI=1S/H2O/h1H2
IUPAC Name
water
SMILES
O

Pharmacology

Indication

For diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered [Label].

Associated Therapies
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
  • Humans and other mammals
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Human Metabolome Database
HMDB0002111
KEGG Drug
D00001
KEGG Compound
C00001
PubChem Compound
962
PubChem Substance
310265058
ChemSpider
937
ChEBI
15377
ChEMBL
CHEMBL1098659
HET
HOH
Drugs.com
Drugs.com Drug Page
Wikipedia
Water
AHFS Codes
  • 40:50.00* — Diluents
  • 52:92.00 — EENT Drugs, Miscellaneous
  • 40:36.00 — Irrigating Solutions
  • 92:92.00 — Other Miscellaneous Therapeutic Agents
PDB Entries
1a65 / 1adl / 1b0k / 1c96 / 1c97 / 1cls / 1dic / 1dmr / 1dz9 / 1ebe
show 79 more
FDA label
Download (97.6 KB)
MSDS
Download (79.7 KB)

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
0CompletedDiagnosticCancer of the Breast / Cancer, Breast / Malignant Melanoma / Melanoma1
0CompletedDiagnosticHepatocellular,Carcinoma1
0CompletedPreventionDental Decay1
0CompletedTreatmentInclusion Body Myositis (IBM)1
0RecruitingDevice FeasibilitySkin Cancers1
0RecruitingHealth Services ResearchDental Decay1
1CompletedNot AvailableHealthy Volunteers1
1CompletedNot AvailableHepatitis C Viral Infection1
1CompletedBasic ScienceDisseminated Sclerosis2
1CompletedBasic ScienceHealthy Volunteers3
1CompletedBasic ScienceHuman Memory / Intranasal Insulin1
1CompletedPreventionFluorosis, Dental1
1CompletedTreatmentAcute and Chronic Inflammation / Autoimmune Diseases / Disorder of Pleura and Pleural Cavity / Disorder of Synovium / Felty's Syndrome / Rheumatoid Arthritis / Rheumatoid Nodules / Sjögren's Syndrome1
1CompletedTreatmentCancer, Advanced / Tumors, Solid1
1CompletedTreatmentDentist-Patient Relations1
1CompletedTreatmentHealthy Volunteers1
1CompletedTreatmentPsoriasis1
1CompletedTreatmentSickle Cell Disorders1
1CompletedTreatmentTumors1
1CompletedTreatmentThrombotic events1
1Not Yet RecruitingDiagnosticCervical Intraepithelial Neoplasia (CIN)1
1Not Yet RecruitingOtherHepatitis C Viral Infection / Swallowing Disorders1
1RecruitingDiagnosticCervical Cancers2
1TerminatedTreatmentRheumatoid Arthritis1
1, 2Active Not RecruitingTreatmentMalignant Neoplasm of Pancreas Metastatic to Peritoneal Surface / Malignant Peritoneal Mesothelioma / Peritoneal Carcinomatosis1
1, 2Active Not RecruitingTreatmentMelanoma1
1, 2CompletedNot AvailableHealthy Volunteers1
1, 2CompletedOtherDyslipidemia (Fredrickson Type Ⅱa) / Hypertriglyceridemias1
1, 2CompletedTreatmentAdenocarcinomas / Neoplasms, Pancreatic1
1, 2CompletedTreatmentChronic Lymphocytic Leukaemia (CLL) / Small Lymphocytic Lymphoma (SLL)1
1, 2CompletedTreatmentHeadaches / Migraines1
1, 2CompletedTreatmentMelanoma1
1, 2Enrolling by InvitationTreatmentFemale Infertility Due to Diminished Ovarian Reserve1
1, 2RecruitingPreventionNecrotizing Enterocolitis1
1, 2RecruitingTreatmentMultiple Sclerosis, Primary Progressive / Relapsing Remitting Multiple Sclerosis (RRMS) / Secondary Progressive Multiple Sclerosis (SPMS)1
1, 2TerminatedTreatmentCarcinoma, Colorectal / Colorectal Cancers / Colorectal Tumors / Neoplasms, Colorectal1
1, 2TerminatedTreatmentRenal Cell Adenocarcinoma1
1, 2WithdrawnTreatmentDiabetes, Diabetes Mellitus Type 11
1, 2WithdrawnTreatmentMelanoma1
2Active Not RecruitingPreventionGraft Versus Host Disease (GVHD)1
2Active Not RecruitingPreventionHigh-Grade Squamous Intraepithelial Lesions / Human Papillomavirus1
2Active Not RecruitingTreatmentLupus Erythematosus, Chronic Cutaneous / Lupus Erythematosus, Cutaneous / Lupus Erythematosus, Discoid1
2Active Not RecruitingTreatmentMucocutaneous Lymph Node Syndrome1
2CompletedBasic ScienceDisseminated Sclerosis1
2CompletedPreventionVaricella / Varicella (Chickenpox)1
2CompletedSupportive CareOral Mucositis1
2CompletedTreatmentAcute Lung Injury (ALI) / Obliterative Bronchiolitis / Respiratory Distress Syndrome, Adult1
2CompletedTreatmentCystic Fibrosis (CF)1
2CompletedTreatmentDisseminated Sclerosis1
2CompletedTreatmentGraft Versus Host Disease (GVHD)1
2CompletedTreatmentHIV I Infection / Human Immunodeficiency Virus (HIV) Infections1
2CompletedTreatmentHand, Foot, and Mouth Disease1
2CompletedTreatmentHidradenitis Suppurativa (HS)2
2CompletedTreatmentHuman Immunodeficiency Virus (HIV) Infections1
2CompletedTreatmentMultiple Myeloma (MM)1
2CompletedTreatmentMycosis Fungoides (MF) / Neoplasms, Hematologic / T-Cell Lymphomas1
2CompletedTreatmentPeriodontitis / Premature Birth of Newborn1
2CompletedTreatmentPersistent Knee Joint Synovitis1
2CompletedTreatmentPost-Operative Pain1
2CompletedTreatmentPsoriasis1
2CompletedTreatmentRelapsing Remitting Multiple Sclerosis (RRMS)1
2CompletedTreatmentRheumatoid Arthritis1
2CompletedTreatmentRheumatoid Arthritis, Juvenile / Uveitis1
2CompletedTreatmentTooth Erosion1
2CompletedTreatmentUlcerative Colitis (UC)1
2Enrolling by InvitationTreatmentIndocyanine Green / Stomach Neoplasms1
2RecruitingTreatmentDiabetes, Diabetes Mellitus Type 1 / Transplant, Kidney1
2RecruitingTreatmentPost-Operative Pain1
2RecruitingTreatmentTinea Pedis1
2SuspendedTreatmentPrimary Systemic Amyloidosis1
2TerminatedTreatmentLeukemias1
2TerminatedTreatmentNephritis, Lupus1
2TerminatedTreatmentRheumatoid Arthritis1
2TerminatedTreatmentVesicular Stomatitis1
2Unknown StatusTreatmentAcute Lung Injury (ALI) / Respiratory Distress Syndrome, Adult1
2Unknown StatusTreatmentAnkylosing Spondylitis (AS)1
2Unknown StatusTreatmentSpondyloarthritis1
2WithdrawnTreatmentCancer, Advanced / Tumors, Solid1
2WithdrawnTreatmentCholestasis / Liver Diseases1
2, 3CompletedTreatmentChronic Hepatitis C Virus (HCV) Infection1
2, 3RecruitingTreatmentDrug-Induced Liver Injury1
2, 3RecruitingTreatmentSepsis1
2, 3TerminatedDiagnosticBone Cancer / Lung Cancers / Neoplasms Metastasis / Prostate Cancer1
2, 3WithdrawnPreventionNeonatal Mortality Rate / Neonatal Sepsis1
2, 3WithdrawnTreatmentChronic Idiopathic Urticaria1
3Active Not RecruitingTreatmentRheumatoid Arthritis1
3CompletedNot AvailableDisseminated Sclerosis2
3CompletedPreventionBreast Cancer With Low to Intermediate HER2 Expression1
3CompletedPreventionChicken-pox Illness (Varicella Virus Disease)1
3CompletedPreventionDiphtheria / Haemophilus Infections / Haemophilus Influenzae Type B / Meningococcal Infections / Pertussis / Tetanus / Viral Hepatitis B / Whole Cell Pertussis1
3CompletedPreventionFlu caused by Influenza1
3CompletedPreventionMumps / Rubella / Rubeola / Varicella2
3CompletedPreventionVaricella1
3CompletedTreatmentAcute Major Bleeding / Disorders, Blood Coagulation1
3CompletedTreatmentCancer, Breast / Menopause / Painful Intercourse / Vulvodynia1
3CompletedTreatmentDisseminated Sclerosis1
3CompletedTreatmentGynecological Laparoscopy1
3CompletedTreatmentHypothyroxinemia1
3CompletedTreatmentJuvenile Idiopathic Arthritis (JIA)1
3CompletedTreatmentMelanoma / Neoplasms Metastasis1
3CompletedTreatmentPain NOS1
3CompletedTreatmentPalmoplantaris Pustulosis1
3CompletedTreatmentPsoriasis1
3CompletedTreatmentPsoriasis Vulgaris (Plaque Psoriasis)1
3CompletedTreatmentReversal of Coagulopathy1
3CompletedTreatmentRheumatoid Arthritis1
3RecruitingDiagnosticColonoscopy1
3RecruitingSupportive CarePain NOS1
3RecruitingTreatmentBiomarkers / Gram-Negative Bacteria Infection / Multiple Organ Failure / Pneumonia / Respiratory Distress Syndrome (RDS) / Sepsis / The Mortality Rate1
3RecruitingTreatmentHCG; IVF; Pregnancy Rates; ART; Chorionic Gonadotropin1
3RecruitingTreatmentHeart Disease End Stage / Heart Failure,Congestive1
3RecruitingTreatmentRelapsing Remitting Multiple Sclerosis (RRMS)1
3RecruitingTreatmentSignificant Bleeding Risk1
3TerminatedTreatmentDisseminated Sclerosis1
3TerminatedTreatmentRheumatoid Arthritis, Juvenile1
3Unknown StatusTreatmentHELLP Syndrome1
3WithdrawnTreatmentGastro-intestinal Neuroendocrine Tumors1
3WithdrawnTreatmentHypertrophic Scars / Minor burns1
4CompletedNot AvailableAnkylosing Spondylitis (AS)2
4CompletedNot AvailableArthritis / Rheumatoid1
4CompletedNot AvailableDisseminated Sclerosis1
4CompletedNot AvailableFevers1
4CompletedBasic ScienceDisseminated Sclerosis1
4CompletedDiagnosticMalignancies1
4CompletedDiagnosticStomach Neoplasms1
4CompletedPreventionMouthwash / Oral Biofilm / Periodontitis1
4CompletedTreatmentActive Rheumatoid Arthritis / Rheumatoid Arthritis1
4CompletedTreatmentAnkylosing Spondylitis (AS)1
4CompletedTreatmentAtopic Dermatitis (AD)1
4CompletedTreatmentCesarean Section1
4CompletedTreatmentCirrhosis of the Liver / Hepatic Encephalopathy1
4CompletedTreatmentConjunctival Intraepithelial Neoplasia / Corneal Intraepithelial Neoplasia1
4CompletedTreatmentEndocrine ophthalmopathy1
4CompletedTreatmentMeconium Ileus / Very Low Birth Weight Infant1
4CompletedTreatmentMelanoma / Non-Melanoma Skin Cancer (NMSC) / Psoriasis1
4CompletedTreatmentPain NOS1
4CompletedTreatmentProcedural Pain1
4CompletedTreatmentPsoriasis4
4CompletedTreatmentPsoriasis Vulgaris (Plaque Psoriasis)1
4CompletedTreatmentPsoriasis / Sleep Apnea, Obstructive1
4CompletedTreatmentPsoriatic Arthritis1
4CompletedTreatmentRespiratory-Gated Imaging Techniques1
4CompletedTreatmentRheumatoid Arthritis3
4CompletedTreatmentSmall intestinal obstruction1
4CompletedTreatmentSpondyloarthritis, Axial1
4Enrolling by InvitationPreventionCartilage-hair Hypoplasia1
4Enrolling by InvitationPreventionFevers / Influenza-like Illness / Severe or persistent diarrhea / Upper Respiratory Disease1
4Enrolling by InvitationTreatmentBlood Loss,Surgical / Cardiovascular Surgical Procedures / Fresh Frozen Plasma / Haemorrhage / Prothrombin Complex Concentrates1
4Not Yet RecruitingBasic ScienceType 2 Diabetes Mellitus1
4Not Yet RecruitingDiagnosticLymphedema of the extremities1
4Not Yet RecruitingPreventionBiofilms / Oils, Essential / Periodontitis1
4Not Yet RecruitingPreventionBiofilms / Oils, Essential / Substantivity1
4Not Yet RecruitingTreatmentAnkylosing Spondylitis (AS)1
4RecruitingBasic ScienceRheumatoid Arthritis1
4RecruitingPreventionHepatitis A / Rubeola / Varicella1
4RecruitingPreventionPostoperative Complications1
4RecruitingTreatmentLymphoma, T-Cell, Cutaneous / Mycosis Fungoides (MF)1
4RecruitingTreatmentPain Due to Certain Specified Procedures1
4RecruitingTreatmentPancreatitis, Chronic; Diabetes; Transplant1
4RecruitingTreatmentRheumatoid Arthritis2
4TerminatedPreventionInfants, Premature1
4TerminatedTreatmentAnkylosing Spondylitis (AS)1
4TerminatedTreatmentRelapsing Remitting Multiple Sclerosis (RRMS)1
4TerminatedTreatmentRheumatoid Arthritis1
4TerminatedTreatmentRheumatoid Arthritis / Vascular Inflammation1
4Unknown StatusSupportive CareNasal Surgery1
4Unknown StatusTreatmentArthritis / Rheumatoid Arthritis1
4Unknown StatusTreatmentJuvenile Idiopathic Arthritis (JIA)1
4Unknown StatusTreatmentMyocardial Infarction1
4Unknown StatusTreatmentPsoriasis1
4WithdrawnBasic ScienceRheumatoid Arthritis1
4WithdrawnPreventionAcute Kidney Injury (AKI)1
Not AvailableActive Not RecruitingDiagnosticEndometrial Clear Cell Adenocarcinoma / Endometrial Mixed Adenocarcinoma / Endometrial Serous Adenocarcinoma / Grade 3 Endometrial Endometrioid Adenocarcinoma / Gynecologic Cancers / Malignant Mixed Mesodermal (Mullerian) Tumor1
Not AvailableCompletedNot AvailableAnkylosing Spondylitis (AS)1
Not AvailableCompletedNot AvailableAnkylosing Spondylitis (AS) / Psoriatic Arthritis / Rheumatoid Arthritis1
Not AvailableCompletedNot AvailableDisseminated Sclerosis1
Not AvailableCompletedNot AvailableDisseminated Sclerosis / Pregnancy / Prenatal Exposure Delayed Effects1
Not AvailableCompletedNot AvailableHemorrhage1
Not AvailableCompletedNot AvailableJuvenile Idiopathic Arthritis (JIA)1
Not AvailableCompletedNot AvailablePregnancy1
Not AvailableCompletedNot AvailablePsoriasis1
Not AvailableCompletedNot AvailablePsoriasis Arthritis / Rheumatoid Arthritis1
Not AvailableCompletedNot AvailablePsoriasis / Psoriatic Arthritis / Skin Diseases, Papulosquamous1
Not AvailableCompletedNot AvailableRheumatoid Arthritis2
Not AvailableCompletedBasic ScienceHealthy Volunteers1
Not AvailableCompletedBasic ScienceHydration1
Not AvailableCompletedHealth Services ResearchCongenital Hypoplastic Anemia1
Not AvailableCompletedTreatmentAcquired Immune Deficiency Syndrome (AIDS) / Human Immunodeficiency Virus (HIV) Infections1
Not AvailableCompletedTreatmentChronic Daily Headache1
Not AvailableCompletedTreatmentCoronary Artery Disease / Inflammatory Reaction / Rheumatoid Arthritis1
Not AvailableCompletedTreatmentDisseminated Sclerosis1
Not AvailableCompletedTreatmentIdiopathic Epiretinal Membrane, Cataract1
Not AvailableCompletedTreatmentMetabolic Syndromes2
Not AvailableCompletedTreatmentPain NOS1
Not AvailableCompletedTreatmentPsoriasis1
Not AvailableCompletedTreatmentRepeated Implantation Failure1
Not AvailableCompletedTreatmentRheumatoid Arthritis1
Not AvailableCompletedTreatmentSoft Tissue Anaesthesia1
Not AvailableEnrolling by InvitationTreatmentCancer, Breast / Sentinel Lymph Node1
Not AvailableRecruitingNot AvailableAbove Knee Amputation / Below Knee Amputation / Lower Extremity Amputation / Wound Healing1
Not AvailableRecruitingNot AvailableBladder Cancers / Malignant Neoplasm of Stomach1
Not AvailableRecruitingNot AvailableHemophilia1
Not AvailableRecruitingNot AvailableHemorrhage1
Not AvailableRecruitingBasic ScienceLymphedema, Secondary1
Not AvailableRecruitingDiagnosticDysuria / Hematuria / Recurrent Uti1
Not AvailableRecruitingPreventionNeonatal Respiratory Distress Syndrome1
Not AvailableTerminatedNot AvailableAnkylosing Spondylitis (AS) / Rheumatoid Arthritis1
Not AvailableTerminatedPreventionBMI >30 kg/m2 / High Blood Pressure (Hypertension) / Hyperlipidemias / Metabolic Syndromes / Psoriasis1
Not AvailableTerminatedPreventionInfants / Newborn Diseases1
Not AvailableUnknown StatusNot AvailableCarpal Tunnel Syndrome (CTS)1
Not AvailableUnknown StatusTreatmentWound site1
Not AvailableWithdrawnTreatmentChronic Regional Pain Syndrome / CRP1
Not AvailableWithdrawnTreatmentIntracranial Hemorrhage, Spontaneous / Intracranial Hemorrhage, Traumatic1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
LiquidOral99.9974 g/100L
LiquidOral99.9974 g/100mL
Liquid; powder, for solutionIntravenous
LiquidRespiratory (inhalation)100 %
Kit; powder, for solutionIntravenous
Injection, solutionIntramuscular1 mL/1mL
Injection, solutionIntramuscular; Intravenous; Subcutaneous1 mg/1mL
Injection, solutionIntramuscular; Intravenous; Subcutaneous1 mL/1mL
SolutionIntramuscular; Intravenous; Subcutaneous1 mL/1mL
LiquidIntramuscular; Intravenous; Subcutaneous100 %
LiquidIntracavernous99.1 %
RinseOphthalmic98.6 mL/100mL
LiquidOphthalmic98 mL/100mL
Kit; liquid; powder, for solutionIntracavernous
LiquidOphthalmic0.99 mL/1mL
LiquidOphthalmic99 mL/100mL
KitTopical98.577 mL/100mL
LiquidIntramuscular; Intravenous; Subcutaneous1 ml
LiquidOphthalmic98.4 mL/100mL
LiquidOphthalmic0.983 mg/1mL
For solutionOphthalmic14.85 mL/15mL
LiquidIrrigation999.1 mg/1mL
LiquidTopical0.991 mL/1mL
Kit; liquid; powder, for solutionSubcutaneous
LiquidOphthalmic98.3 mL/100mL
SolutionOphthalmic99.05 mL/100mL
SolutionOphthalmic986 mg/1mL
LiquidOphthalmic983 mg/1mL
LiquidOphthalmic991 mg/1mL
SolutionOphthalmic991 mg/1mL
Solution / dropsIntraocular980 mg/1mL
SolutionOphthalmic
SolutionOphthalmic980 mg/1mL
LiquidOphthalmic92.2 mL/100mL
LiquidTopical991 mg/1mL
SolutionOphthalmic14.85 mL/15mL
SolutionCutaneous; Irrigation; Ophthalmic; Topical985.77 g/1000mL
SolutionOphthalmic0.929 g/946mL
Kit
Solution, concentrateCutaneous; Irrigation; Ophthalmic; Topical889.6 g/1000mL
LiquidOphthalmic990 mL/1L
LiquidOphthalmic232.6 mg/236mL
LiquidIntravesical
Injection, solutionIntravenous; Subcutaneous1 mL/1mL
Kit; liquid; powder, for solutionIntralesional; Intramuscular; Intravenous; Subcutaneous
Liquid; powder, for solutionIntralesional; Intramuscular; Intravenous; Subcutaneous
Liquid; powder, for solutionIntralesional; Intramuscular; Subcutaneous
Kit; liquid; powder, for solutionIntravenous
Powder, for solutionIntravenous
SolutionOphthalmic0.983 mg/1mL
Powder, for solutionIntramuscular; Intravenous
KitOphthalmic; Respiratory (inhalation); Topical
Kit; powder, for solutionIntramuscular; Subcutaneous
LiquidOphthalmic99.01 mL/100mL
LiquidOphthalmic0.988 mL/1mL
LiquidOphthalmic99.1 mL/100mL
LiquidIntravenous
SolutionOphthalmic929 g/946mL
LiquidOphthalmic95.1 mL/100mL
Kit; liquid; powder, for solutionIntramuscular
Kit; liquid; powder, for solutionIntramuscular; Subcutaneous
Liquid; powder, for solutionIntramuscular; Subcutaneous
Liquid; powder, for solutionIntramuscular
Powder, for solutionIntramuscular
SolutionOphthalmic473 mL/473mL
Solution / dropsOphthalmic99.03 mL/100mL
SolutionOphthalmic98.577 mL/100mL
IrrigantIrrigation; Ophthalmic98.3 mL/100mL
Kit991 mg/1mL
SolutionOphthalmic.9905 mL/1mL
Solution / dropsOphthalmic99.05 mL/100mL
SolutionOphthalmic98.3 mL/100mL
SolutionOphthalmic98.5 mL/100mL
Powder, for solutionSubcutaneous
IrrigantTopical98 mL/100mL
LiquidOphthalmic98.6 mL/100mL
LiquidOphthalmic99.8 mL/100mL
Kit; powder, for solutionSubcutaneous
InjectionSubcutaneous0.7 mL/0.7mL
Injection, solutionSubcutaneous1 mL/1mL
LiquidParenteral100 %
LiquidOphthalmic98.16 mL/100mL
SolutionOphthalmic0.987 mL/1mL
InjectionIntramuscular; Intravenous; Subcutaneous1 mL/1mL
InjectionIntravenous1 mL/1mL
InjectionParenteral1 mL/1mL
Injection, solutionIntramuscular; Intravenous; Subcutaneous50 mL/50mL
Injection, solutionIntravenous1 mL/1mL
Injection, solutionIntravenous100 mL/100mL
Injection, solutionIntravenous1000 mL/1000mL
IrrigantIrrigation1 mL/1mL
IrrigantIrrigation100 mL/100mL
LiquidIntravenous1 mL/1mL
SolutionIntravenous1 mL/1mL
SolutionIntravenous5 mL/5mL
LiquidIntravenous
LiquidParenteral
LiquidIntramuscular; Intraperitoneal; Intravenous; Subcutaneous100 %
LiquidIntravascular1 ml
LiquidIntravenous100 %
LiquidParenteral10 ml
LiquidParenteral2 ml
SolutionIntramuscular; Intraperitoneal; Intravenous; Subcutaneous100 %
SolutionIntramuscular; Intravenous; Subcutaneous100 %
SolutionIntravenous100 %
LiquidIntraperitoneal; Irrigation100 %
LiquidIntraperitoneal; Irrigation; Topical100 %
LiquidIrrigation100 %
Solution, concentrateCutaneous; Irrigation; Ophthalmic; Topical992.96 g/1000mL
LiquidTopical473.6 g/475mL
LiquidOphthalmic99.05 mL/100mL
LiquidIntramuscular; Intravenous; Subcutaneous
SolutionOphthalmic0.98 mL/1mL
Paste, dentifriceTopical
Prices
Not Available
Patents
Not Available

Properties

State
Liquid
Experimental Properties
PropertyValueSource
melting point (°C)0MSDS
boiling point (°C)100MSDS
water solubilityCompletely miscibleMSDS
Predicted Properties
PropertyValueSource
logP-0.65ChemAxon
pKa (Strongest Acidic)15.7ChemAxon
pKa (Strongest Basic)-1.8ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area25.3 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity3.7 m3·mol-1ChemAxon
Polarizability1.51 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Mass Spectrum (Electron Ionization)MSsplash10-014i-9000000000-f7ee14225b4277f6218c
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-9000000000-1a741e1ffb75284635fc
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-9000000000-1a741e1ffb75284635fc
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-9000000000-1a741e1ffb75284635fc
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-9000000000-a2a06393708ba68baab0
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-9000000000-a2a06393708ba68baab0
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-9000000000-a2a06393708ba68baab0
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-0006-0940000000-08a1813d85727d668cf4
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-0a4l-0980000000-5b109ff45e0e5e5051ae
1H NMR Spectrum1D NMRNot Applicable

Taxonomy

Description
This compound belongs to the class of inorganic compounds known as homogeneous other non-metal compounds. These are inorganic non-metallic compounds in which the largest atom belongs to the class of 'other non-metals'.
Kingdom
Inorganic compounds
Super Class
Homogeneous non-metal compounds
Class
Homogeneous other non-metal compounds
Sub Class
Not Available
Direct Parent
Homogeneous other non-metal compounds
Alternative Parents
Not Available
Substituents
Homogeneous other non metal
Molecular Framework
Not Available
External Descriptors
oxygen hydride, mononuclear parent hydride, inorganic hydroxy compound (CHEBI:15377) / a small molecule (WATER)

Drug created on October 01, 2015 10:19 / Updated on November 13, 2018 08:06